Bellevue Asset Management »

Cytokinetics shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0k 19 54.95
2024-09-30 $1.0k 19 52.79
2024-06-30 $1.0k 19 54.16

More positions owned by Bellevue Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Capital Group Growth Etf Shs Creation Uni (CGGR)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchange- Traded Fst Low Oppt Etf (LMBS)
Costco Wholesale Corporation (COST)
Amazon (AMZN)
Jp Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Fds Inf Tech Etf (VGT)
Tcw Etf Trust Flexible Income (FLXR)
Jp Morgan Exchange Traded F Short Dura Core (JSCP)
First Tr Exchange-traded First Tr Enh New (FTSM)
Starbucks Corporation (SBUX)
Blackrock Etf Trust Ishares Technolo (TEK)

View all positions for Bellevue Asset Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Polar Capital Holdings
Rtw Investments
Susquehanna International
Integral Health Asset Management
Armistice Capital
UBS Group
Citadel Advisors

View all funds holding Cytokinetics